Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05327101 · ClinicalTrials.gov registry record

Patient Preferences for Leadless Pacemakers

A clinical trial of Bradycardia and Cardiac Pacemaker, Artificial, sponsored by Abbott Medical Devices.

Completed
Registry status
117
Enrollment target
11
Study locations

NCT05327101 is a study of Bradycardia and Cardiac Pacemaker, Artificial that has completed, run by Abbott Medical Devices. The registered enrollment target is 117 participants, below the 4,409-participant average among 29 other Bradycardia trials with a reported enrollment target (97% lower). The trial reports 11 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05327101, a study of Bradycardia and Cardiac Pacemaker, Artificial, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
117 participants
Enrollment target
11
Study locations

Study Summary

Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers

Interventions

  • OTHER Patient Preference Survey

Study Locations (11)

Arkansas

  • Arrhythmia Research Group - Jonesboro
  • Arkansas Heart Hospital - Little Rock

Illinois

  • Rush University Medical Center - Chicago
  • Prairie Education & Research Cooperative - Springfield

Arizona

  • Honor Health - Scottsdale

California

  • Pacific Heart Institute - Santa Monica

Florida

  • Baptist Medical Center - Jacksonville

Massachusetts

  • Charlton Memorial Hospital - Fall River

New York

  • New York Presbyterian Hospital/Cornell University - New York

Oklahoma

  • Hightower Clinical - Oklahoma City

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2022-03-28
Est. Completion 2023-06-13

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT05327101

The ClinicalTrials.gov registry entry for NCT05327101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,409-participant average among 29 other Bradycardia trials with a reported enrollment target (97% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Patient Preference Survey is the first listed.

NCT05327101 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Arkansas, Illinois, Arizona.

Frequently Asked Questions

What is clinical trial NCT05327101 about?

NCT05327101 is a clinical study titled "Patient Preferences for Leadless Pacemakers". Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers

What is the current status of trial NCT05327101?

This trial is currently completed. The enrollment target is 117 participants. The study started on 2022-03-28. Estimated completion is 2023-06-13.

What conditions does trial NCT05327101 study?

This clinical trial studies the following conditions: Bradycardia, Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder.

What interventions are being tested in trial NCT05327101?

The interventions under investigation include: Patient Preference Survey (OTHER).

Who is sponsoring clinical trial NCT05327101?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05327101 being conducted?

This trial has 11 study locations across Arizona, Arkansas, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.